Finnrick - Ensuring a Safer and More Transparent Supply Chain
Mai Peptide

Mai Peptide
Retatrutide

Finnrick tested 7 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Mai Peptide between 4 Nov 2025 and 29 Dec 2025. Test scores average below 4 or some scores below 3, and at least 6 tests, warrant a confident Finnrick Rating of E (Bad).

Finnrick Rating™
E
BAD
Mai Peptide
Retatrutide
Tested 7 Samples
Last test 29 Dec 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Retatrutide tests from Mai Peptide

Samples are tested in commercial labs

Tests Count

7

Scores

AVG7.3MIN2.2MAX9.7

Last

29 Dec 2025

First

4 Nov 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
29 Dec 2025View8.010mg9.56mg-4.4%99.95%(no batch ID)No Label / Copper Crimp / Clear CapLab EPublic
29 Dec 2025View2.210mg8.29mg-17.1%81.94%(no batch ID)No Label / Silver Crimp / Green CapLab EPublic
13 Dec 2025View6.415mg15.2mg+1.3%99.20%(no batch ID)White Label / Silver Crimp / Clear CapLab GPublic
12 Dec 2025View9.710mg10.6mg+6.0%99.95% October 8, 2025No Label / Silver Crimp / Clear Blue CapLab EPublic
23 Nov 2025View9.430mg31.8mg+6.0%99.80%October 8, 2025No Label / Silver Crimp / Pink CapLab GPublic
14 Nov 2025View8.415mg16.4mg+9.3%99.80% 09/04/2025No Label / Copper Crimp / Clear CapLab GPublic
4 Nov 2025View7.310mg11.1mg+11.0%99.50%September 6, 2025No Label / Silver Crimp / Clear Blue CapLab GPublic